Availability: In Stock
Availability: In Stock
In 2001, Allergan developed a medicated eye drop called bimatoprost to treat glaucoma. By a stroke of serendipity, many of the patients noticed something happening to their eyelashes. Their eyelashes grew longer, fuller, and darker while on the medication. This unexpected side effect prompted Allergan to study bimatoprost for the use in eyelash hypotrichosis, which is the medical term for an inadequate amount of hair.
The study produced remarkable results. At week 16, patients had an average of 1.4 mm growth in length (25 percent increase) and a 106 percent increase in fullness and thickness. The results of the study resulted in Latisse® become the first and only FDA-approved treatment to lengthen, darken, and thicken eyelashes for people with insufficient lashes.
A simple and effective cosmetic eye lift without the surgery, with just two drops of Upneeq®
Most patients in clinical trials had a lift in their eyelids in as little as 2 hours
• 84% of patients had some form of improvement
• 74% of patients had more than a 50% improvement
In one study, some patients saw a lift in their eyelids as fast as 5 minutes after the first dose
SELECT UPNEEQ® OR LATISSE®
You can choose whether you want it one-time or on auto-ship
PROVIDE SOME MEDICAL HISTORY
Complete a secure and brief questionnaire
UPLOAD PHOTOS OR COMPLETE A VIDEO CONSULTATION
Provide a current photo of your full face and an image of your valid, state-issued ID or Complete Video Consultation*
PRIVACY POLICY